Spots Global Cancer Trial Database for Can We Miss Pigmented Lesions in Psoriasis Patients?
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Can We Miss Pigmented Lesions in Psoriasis Patients?
Official Title: Can We Miss Pigmented Lesions in Psoriasis Patients?
Study ID: NCT01053819
Interventions
Study Description
Brief Summary: In psoriasis patients, thick psoriatic plaques can obscure these lesions, and clinicians rely heavily on visual inspection to recognize suspicious or atypical pigmented lesions. However, successful systemic treatment and subsequent clearing of psoriatic plaques may allow clinicians to better evaluate pigmented lesions, thereby increasing the likelihood of early identification and treatment of suspicious lesions such as nonmelanoma skin cancer and malignant melanoma.
Detailed Description: No further description is desired.
Eligibility
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
UAB Dermatology, Birmingham, Alabama, United States
Contact Details
Name: Boni E Elewski, MD
Affiliation: University of Alabama at Birmingham
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
